Weave Bio Establishes Inaugural Strategic Advisory Board

Weave’s new Strategic Advisory Board brings together senior leaders from Boehringer Ingelheim, Takeda, Gilead, Serrado Capital, and Stanford University. These leaders shape how the industry operates today, and where it must go tomorrow. Their guidance will keep Weave building technology that earns trust, not just power. The board marks the next step in Weave’s momentum, following a $20 million Series A round and a strategic partnership with Parexel.

View the press release